Capstone Investment Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,300
Closed -$238K 1581
2024
Q4
$238K Sell
3,300
-2,700
-45% -$211K ﹤0.01% 1546
2024
Q3
$489K Buy
6,000
+600
+11% +$48K ﹤0.01% 1217
2024
Q2
$401K Buy
5,400
+900
+20% +$67.5K ﹤0.01% 1423
2024
Q1
$351K Sell
4,500
-9,600
-68% -$714K ﹤0.01% 1745
2023
Q4
$1.01M Buy
14,100
+2,200
+18% +$153K ﹤0.01% 1049
2023
Q3
$826K Buy
11,900
+2,000
+20% +$151K ﹤0.01% 1057
2023
Q2
$802K Buy
9,900
+600
+6% +$49K ﹤0.01% 949
2023
Q1
$751K Buy
9,300
+3,800
+69% +$306K ﹤0.01% 877
2022
Q4
$411K Buy
5,500
+1,300
+31% +$92.6K ﹤0.01% 1171
2022
Q3
$271K Buy
4,200
+600
+17% +$41.6K ﹤0.01% 1407
2022
Q2
$249K Sell
3,600
-22,600
-86% -$1.68M ﹤0.01% 1372
2022
Q1
$2.01M Sell
26,200
-12,500
-32% -$899K 0.01% 1046
2021
Q4
$2.96M Buy
38,700
+1,800
+5% +$132K 0.01% 988
2021
Q3
$2.72M Buy
36,900
+12,500
+51% +$937K 0.01% 1092
2021
Q2
$1.63M Buy
24,400
+9,400
+63% +$628K ﹤0.01% 1096
2021
Q1
$1.12M Buy
15,000
+7,200
+92% +$547K ﹤0.01% 1084
2020
Q4
$568K Buy
7,800
+4,900
+169% +$346K ﹤0.01% 1223
2020
Q3
$193K Sell
2,900
-3,400
-54% -$215K ﹤0.01% 1284
2020
Q2
$359K Sell
6,300
-300
-5% -$14.7K ﹤0.01% 1146
2020
Q1
$232K Sell
6,600
-500
-7% -$23.8K ﹤0.01% 997
2019
Q4
$371K Sell
7,100
-400
-5% -$19.9K ﹤0.01% 1193
2019
Q3
$379K Sell
7,500
-300
-4% -$14.8K ﹤0.01% 1143
2019
Q2
$375K Buy
7,800
+1,000
+15% +$46.2K ﹤0.01% 1161
2019
Q1
$329K Buy
6,800
+5,200
+325% +$234K ﹤0.01% 1057
2018
Q4
$66K Buy
1,600
+100
+7% +$4.1K ﹤0.01% 1168
2018
Q3
$61K Buy
+1,500
New +$60.6K ﹤0.01% 1193

Other funds holding HOLX

Capstone Investment Advisors's HOLX Position: Q1 2026 in Review

Capstone Investment Advisors reduced its Hologic (HOLX) stake by 68% in Q1 2026, selling an estimated $17.2M and leaving 108,000 shares worth $8.16M. The position accounts for 0.01% of the portfolio, ranked #333.

Capstone Investment Advisors first reported a position in HOLX in Q4 2015 and has held it in 24 quarters since. The position peaked at $25.1M in Q4 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Capstone Investment Advisors held 108,000 shares of Hologic worth $8.16M as of Q1 2026.
  • Capstone Investment Advisors sold 228,740 Hologic shares in Q1 2026, an estimated $17.2M.
  • Hologic made up 0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #333 holding.
  • Capstone Investment Advisors first reported a position in Hologic in Q4 2015 and has held it in 24 quarters since.
  • Capstone Investment Advisors's Hologic position peaked at $25.1M in Q4 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.